D. Thye

发表

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

C. Schumann, T. File, P. Eckburg, 2011, The Journal of antimicrobial chemotherapy.

CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections

P. Eckburg, G. Witherell, T. O'Neal, 2012, Antimicrobial Agents and Chemotherapy.

Prospective Study of the Wilson Severity-of-Illness Scoring System for Complicated Skin and Skin Structure Infections

G. Talbot, Anita F. Das, T. O'Neal, 2012, Antimicrobial Agents and Chemotherapy.

Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial 2

P. Eckburg, G. Witherell, T. O'Neal, 2012 .

Day 4 Clinical Response of Ceftaroline Fosamil Versus Ceftriaxone for Community-Acquired Bacterial Pneumonia

P. Eckburg, G. Witherell, H. D. Friedland, 2012 .

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

J. Milanowski, T. File, D. Górecka, 2011, The Journal of antimicrobial chemotherapy.

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.

T. Riccobene, I. Critchley, D. Thye, 2010, The Journal of antimicrobial chemotherapy.

Review of ceftaroline fosamil microbiology: integrated FOCUS studies.

P. Eckburg, I. Critchley, A. Jandourek, 2011, The Journal of antimicrobial chemotherapy.

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

M. Wilcox, G. Talbot, G. Corey, 2010, The Journal of antimicrobial chemotherapy.

Transforming growth factor‐β, osteogenin, and bone morphogenetic protein‐2 inhibit intercellular communication and alter cell proliferation in MC3T3‐E1 cells

Timothy A. Miller, G. Rudkin, K. Ishida, 1996 .

Transforming growth factor-beta, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cells.

G. Rudkin, K. Ishida, D. Yamaguchi, 1996, Journal of cellular physiology.

Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults

D. Thye, T. Sandison, V. Ong, 2016, Antimicrobial Agents and Chemotherapy.

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.

M. Wilcox, G. Witherell, G. Talbot, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The isolation of a fibroblast growth inhibitor associated with perigraft seroma.

D. Williams, D. Thye, S. Ahn, 1994, Journal of vascular surgery.

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.

F. Trautinger, M. Wilcox, L. Bush, 2010, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

Ronald N. Jones, M. Castanheira, G. Drusano, 2011, Antimicrobial Agents and Chemotherapy.

Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.

T. File, P. Eckburg, D. Low, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections

G. Talbot, Anita F. Das, D. Thye, 2007, Antimicrobial Agents and Chemotherapy.

Efficacy of Ceftaroline Fosamil for Bacteremia Associated With Community-Acquired Bacterial Pneumonia

P. Eckburg, A. Jandourek, H. D. Friedland, 2014, Hospital practice.

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.

M. Wilcox, G. Talbot, Anita F. Das, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.